North America CAR-T Cell Therapy Treatment Market to 2032
Overview
The North America CAR-T Cell Therapy Treatment Market is expected to reach a 16.22 USD Billion by 2032 and is projected to grow at a CAGR of 56.71% from 2025 to 2032.
Revenue, 2024 (USD Billion)
1.98
Forecast, 2032 (USD Billion)
16.22
CAGR, 2024 - 2032
56.71%
Report Coverage
North America
North America CAR-T Cell Therapy Treatment Market 2018-2032 USD Billion
North America CAR-T Cell Therapy Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 1.98 USD Billion
- Projected Market Size (2032): 16.22 USD Billion
- CAGR (2025-2032): 56.71%
Key Findings of North America CAR-T Cell Therapy Treatment Market
- The North America CAR-T Cell Therapy Treatment Market was valued at 1.98 USD Billion in 2024.
- The North America CAR-T Cell Therapy Treatment Market is likely to grow at a CAGR of 56.71% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Antigens On Hematologic Malignancies in Targeted Antigens Segment accounted for the largest share of the market with a revenue of 1.98 USD Billion
- The fastest growing segment Specialty Clinics in End User Segment grew Fastest with a CAGR of 61.07% during the forecast period from 2024 to 2032.
North America CAR-T Cell Therapy Treatment Market Scope
North America CAR-T Cell Therapy Treatment Market Segmentation & Scope
End User
- Others
- Specialty Clinics
- Hospitals
Distribution Channel
- Others
- Hospital Pharmacy
Therapeutic Application
- Others
- Multiple Myeloma
- Hematologic Malignancies
- Lung Cancer
- Chronic Lymphocytic Leukemia
- Gastric Cancer
- Pancreatic Cancer
- Breast Cancer
- Mantle Cell Lymphoma
- Acute Lymphoblastic Leukaemia (ALL)
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
Brand
- Others
- Tecartus
- Kymriah
- Yescarta
Targeted Antigens
- Antigens On Solid Tumors
- Others
- Antigens On Hematologic Malignancies
Structure
- Fourth Generation CAR-T Cells
- Third Generation CAR-T Cells
- First Generation CAR-T Cells
- Second Generation CAR-T Cells
Product
- Allogeneic CAR-T Cells
- Autologous CAR-T Cells
North America CAR-T Cell Therapy Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2019 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 1.98 USD Billion |
| Market Value in 2032 | 16.22 USD Billion |
| CAGR (2025-2032) | 56.71% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User, Distribution Channel, Therapeutic Application, Brand, Targeted Antigens, Structure, Product |
Regional Insights:
-
Leading Market (2024-2032): North America, leading in terms of revenue 1.98 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,949.04 USD Million in 2024.
Segments and Scope
-
North America CAR-T Cell Therapy Treatment Market to 2032, By End User
- Hospitals is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 1.49 USD Billion in the year 2024.
- Specialty Clinics is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 56.24 % in forecast period 2025-2032.
-
North America CAR-T Cell Therapy Treatment Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 1.49 USD Billion in the year 2024.
- Hospital Pharmacy is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 56.24 % in forecast period 2025-2032.
-
North America CAR-T Cell Therapy Treatment Market to 2032, By Therapeutic Application
- Follicular Lymphoma is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 961.09 USD Billion in the year 2024.
- Diffuse Large B-Cell Lymphoma is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 53.92 % in forecast period 2025-2032.
-
North America CAR-T Cell Therapy Treatment Market to 2032, By Brand
- Yescarta is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 961.09 USD Billion in the year 2024.
- Kymriah is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 53.92 % in forecast period 2025-2032.
-
North America CAR-T Cell Therapy Treatment Market to 2032, By Targeted Antigens
- Antigens On Hematologic Malignancies is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 1.98 USD Billion in the year 2024.
- Antigens On Hematologic Malignancies is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 56.71 % in forecast period 2025-2032.
-
North America CAR-T Cell Therapy Treatment Market to 2032, By Structure
- Second Generation CAR-T Cells is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 1.98 USD Billion in the year 2024.
- Second Generation CAR-T Cells is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 56.71 % in forecast period 2025-2032.
-
North America CAR-T Cell Therapy Treatment Market to 2032, By Product
- Autologous CAR-T Cells is the largest segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a revenue of 1.98 USD Billion in the year 2024.
- Autologous CAR-T Cells is the Fastest growing segment in North America CAR-T Cell Therapy Treatment Market to 2032 with a Growth rate of 56.71 % in forecast period 2025-2032.
North America CAR-T Cell Therapy Treatment Market Company Share Analysis
| Company Name |
|
||
| Novartis AG | |||
| Kite Pharma Inc. | |||
North America CAR-T Cell Therapy Treatment Market Geographical Sales Distribution, 2018-2032 USD Billion
North America CAR-T Cell Therapy Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The North America CAR-T Cell Therapy Treatment Market is segmented based on Segmentation End User, Distribution Channel, Therapeutic Application, Brand, Targeted Antigens, Structure, Product.
North America CAR-T Cell Therapy Treatment Market was valued at USD 1.98(Revenue in USD Billion) in 2019.
North America CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 56.71% during the forecast period of 2024 to 2032.
The Antigens On Hematologic Malignancies segment is expected to dominate the North America CAR-T Cell Therapy Treatment Market, holding a largest market share of 1.98 USD Billion in 2024
North America CAR-T Cell Therapy Treatment Market Scope
North America CAR-T Cell Therapy Treatment Market Segmentation & Scope
End User
- Others
- Specialty Clinics
- Hospitals
Distribution Channel
- Others
- Hospital Pharmacy
Therapeutic Application
- Others
- Multiple Myeloma
- Hematologic Malignancies
- Lung Cancer
- Chronic Lymphocytic Leukemia
- Gastric Cancer
- Pancreatic Cancer
- Breast Cancer
- Mantle Cell Lymphoma
- Acute Lymphoblastic Leukaemia (ALL)
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
Brand
- Others
- Tecartus
- Kymriah
- Yescarta
Targeted Antigens
- Antigens On Solid Tumors
- Others
- Antigens On Hematologic Malignancies
Structure
- Fourth Generation CAR-T Cells
- Third Generation CAR-T Cells
- First Generation CAR-T Cells
- Second Generation CAR-T Cells
Product
- Allogeneic CAR-T Cells
- Autologous CAR-T Cells
Frequently Asked Questions
The North America CAR-T Cell Therapy Treatment Market is segmented based on Segmentation End User, Distribution Channel, Therapeutic Application, Brand, Targeted Antigens, Structure, Product.
North America CAR-T Cell Therapy Treatment Market was valued at USD 1.98(Revenue in USD Billion) in 2019.
North America CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 56.71% during the forecast period of 2024 to 2032.
The estimated market value of the North America CAR-T Cell Therapy Treatment Market for final year is USD 16.22 (USD Billion).
North America CAR-T Cell Therapy Treatment Market Company Profiling
Frequently Asked Questions
The North America CAR-T Cell Therapy Treatment Market is segmented based on Segmentation End User, Distribution Channel, Therapeutic Application, Brand, Targeted Antigens, Structure, Product.
North America CAR-T Cell Therapy Treatment Market was valued at USD 1.98(Revenue in USD Billion) in 2019.
North America CAR-T Cell Therapy Treatment Market is projected to grow at a CAGR of 56.71% during the forecast period of 2024 to 2032.
The estimated market value of the North America CAR-T Cell Therapy Treatment Market for final year is USD 16.22 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.